The Global Market for Sleep Apnea Diagnostic and Therapeutic Devices is Projected to Reach US$9.6 Billion by 2024
Rising Incidence of Sleep-Related
Disorders and Technological Advancements Drive the Global Market for Sleep
Apnea Diagnostic & Therapeutic Devices, According to a New Report by Global Industry Analysts,
Inc.
GIA
announces the release of a comprehensive global report on Sleep Apnea
Diagnostic and Therapeutic Devices markets. The global market for Sleep
Apnea Diagnostic and Therapeutic Devices is projected to reach US$9.6 billion
by 2024,
driven by increasing incidence of sleep-related disorders, growing geriatric
population, and technological advancements. Growing prevalence of co-morbid
conditions, such as obesity, type-II diabetes, hypertension, and cardiovascular
diseases; and reimbursement policies are the other growth drivers.
The
global market for sleep apnea diagnostic and therapeutic devices is forecast to
register a healthy growth rate. Technological advancements, rising geriatric
population, and increasing incidence of sleep-related disorders, including
Obstructive Sleep Apnea (OSA), are driving the market for sleep apnea
diagnostic and therapeutic devices. The demand for sleep apnea devices is also
likely to be fueled by growing prevalence of co-morbid conditions, such as
obesity, type-II diabetes, hypertension, and cardiovascular diseases. Existing
reimbursement policies towards sleep disorders, including Medicare and Medicaid
coverage for oral appliances, are expected to fuel the market further. Ongoing
efforts by companies to develop advanced devices that are user-friendly and
offer patient comfort and safety are likely to propel the global demand for
sleep apnea devices. Manufacturers of these devices are also looking forward to
tap lucrative opportunities across emerging economies. Moreover, various
companies are working in association with laboratories, healthcare facilities,
and distributors to increase patient awareness about the condition, and the
available diagnostic and therapeutic options.
Polysomnography (PSG)
devices are
anticipated to provide lucrative growth opportunities owing to the development
of sophisticated products. On the other hand, actigraphy devices represent the
fastest growing category on account of their enhanced sensitivity,
cost-effectiveness, and high usage rates. Perceived as a gold standard for
treating sleep apnea, positive airway pressure (PAP) devices are designed to
ensure normal breathing patterns during sleep. Oral appliances are however
anticipated to exhibit notable penetration on account of the key issues
associated with CPAP devices addressed by them.
As
stated by the new market research report on Sleep Apnea Diagnostic and
Therapeutic Devices, the United States dominates the global sleep apnea diagnostic and
therapeutic devices market. Growing prevalence, along with the pressing need
for diagnosis as well as treatment of sleep apnea is promoting growth of the US
market. Asia-Pacific is expected to register the fastest growth, due to the
large base of undiagnosed sleep apnea patients globally. Increasing number of sleep clinics in the
region, development of affordable devices, and improving healthcare awareness
are the other growth propellers.
Key
players in the market include Cadwell Laboratories Inc., Cleveland Medical
Devices Inc., Compumedics Ltd., DeVilbiss Healthcare, Fisher & Paykel
Healthcare Ltd., Itamar Medical Ltd.,
Natus Medical Inc., Philips Healthcare, ResMed Inc., Teleflex Inc., Löwenstein
Medical Technology GmbH + Co. KG, Vyaire Medical Inc., among others.
The
research report titled “Sleep Apnea Diagnostic and
Therapeutic Devices: A Global Strategic Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market
estimates and projections in thousand dollars for all major geographic markets
such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of
Asia-Pacific), Middle East & Africa, and Latin America (Brazil, and Rest of
Latin America). Product Segments analyzed in the report include Diagnostic
Devices and Therapeutic Devices.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To
connect with us, visit our LinkedIn page.
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA,
All Rights Reserved.
Very useful blog!! Also check out Sleep Apnea specialist in Jaipur.
ReplyDeleteNicely written. Visit this page Snoring Specialist In Jaipur.
ReplyDelete